financetom
Business
financetom
/
Business
/
HCL Tech poised for earnings upgrades, re-rating: Experts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HCL Tech poised for earnings upgrades, re-rating: Experts
Oct 16, 2020 6:06 AM

HCL Technologies reported a strong set of numbers for the September quarter and also raised revenue and margin guidance.

Share Market Live

NSE

Urmil Shah, AVP and Research Analyst at IDBI Capital, Prakash Diwan, Market Expert and Sandip Agarwal, Research Analyst-Institutional Equities at Edelweiss discussed HCL Tech’s performance numbers.

“HCL Tech has set itself up for very high expectation. There is great potential in the product side that they have developed after the IBM acquisition and that will start playing out or making sure that the numbers are resilient enough for quarters to come by,” said Prakash Diwan.

“My price target is quite steep primarily because I firmly believe that we are in a technological upcycle and the way is to upgrade the multiple at the beginning of the cycle,” said Agarwal, who has a target of Rs 1481 on the stock.

“I am pretty confident that as we get into next two-three quarters, we will see numbers getting revised massively by the street and the guidance by the company will also get revised upwards,” Agarwal added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Recursion Pharmaceuticals Shares Are Up Today: what's Going On?
Recursion Pharmaceuticals Shares Are Up Today: what's Going On?
Apr 11, 2025
Shares of Recursion Pharmaceuticals, Inc ( RXRX ). are trading higher Friday after the U.S. Food and Drug Administration announced plans to phase out its requirement for animal testing in favor of more modern, human-relevant methods. The agency stated that it will begin implementing the shift immediately, replacing animal models with AI-based computational toxicity assessments, human cell lines, and organoid-based...
MarketWise Expects Q1 Billings to Rise 26% Sequentially; Shares Up
MarketWise Expects Q1 Billings to Rise 26% Sequentially; Shares Up
Apr 11, 2025
10:58 AM EDT, 04/11/2025 (MT Newswires) -- MarketWise ( MKTW ) said Friday it expects Q1 billings of about $70 million, a more than 26% increase quarter over quarter. The company added that at March 31, it had 473,000 consolidated paid subscribers and 3 million active free subscribers. The company said it plans to release Q1 results no later than...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Leviathan Gold Raises $3.25 Million in Private Placement and Announces Inclusion of Strategic Mining Investor Michael Gentile; Shares Hit 52 Week Highs
Leviathan Gold Raises $3.25 Million in Private Placement and Announces Inclusion of Strategic Mining Investor Michael Gentile; Shares Hit 52 Week Highs
Apr 11, 2025
10:57 AM EDT, 04/11/2025 (MT Newswires) -- Leviathan Gold ( LVXFF ) on Friday rose 12.5% and touched fresh 52 week highs after the company closed a non-brokered private placement pursuant to which the company sold 32.5 million units in the capital of the company at $0.10 apiece for proceeds of $3.25 million. The company added that Michael Gentile will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved